Is It Worth Suppressing Tsh In Low- And Intermediate-Risk Papillary Thyroidcancer Patients Before The First Disease Assessment?

Livia Lamartina, Teresa Montesano, Rosa Falcone, Marco Biffoni, Giorgio Grani, Marianna Maranghi, Laura Ciotti, Laura Giacomelli, Valeria Ramundo, Cristano Lomonaco, Cira Rosaria Di Gioia, Lucia Piernatale, Giuseppe Ronga and Cosimo Durante

Endocrine Practice

Feb 2019, Vol. 25, No. 2 (February 2019) pp. 165-169